Peanut Allergen Threshold Study (PATS): Validation of eliciting doses using a novel single-dose challenge protocol

Allergy, Asthma and Clinical Immunology

Volumn 9, Issue 1, 2013, Pages

  Zurzolo, Giovanni A ^a,b   Allen, Katrina J ^a,c,d   Taylor, Steve L ^e   Shreffler, Wayne G ^f   Baumert, Joseph L ^e   Tang, Mimi L K ^a,c,d   Gurrin, Lyle C ^g   Mathai, Michael L ^b   Nordlee, Julie A ^e   DunnGalvin, Audrey ^h   Hourihane, Jonathan O ^h  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b VICTORIA UNIVERSITY   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Eliciting dose (ED); Food Allergy related Quality of Life Questionnaires (FAQLQ); Oral Food Challenges (OFC); Peanut Allergen Threshold Study (PATS); Peanut thresholds; Single dose; Voluntary Incidental Trace Allergen Labelling (VITAL)

Indexed keywords

FOOD ALLERGEN; PEANUT ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHILD; DIAGNOSTIC ACCURACY; DOSE CALCULATION; DOSE RESPONSE; ELICITING DOSE; FOLLOW UP; GENERAL HOSPITAL; HUMAN; IN VITRO STUDY; INFANT; IRELAND; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PEANUT ALLERGY; PREDICTIVE VALUE; PRESCHOOL CHILD; PROVOCATION TEST; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD; SEROLOGY; SINGLE DRUG DOSE; UNITED STATES; UNIVERSITY HOSPITAL; VALIDATION STUDY;

EID: 84887641776     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/1710-1492-9-35     Document Type: Article

References (21)

1. Allen KJ, Remington BC, Baumert JL, Crevel R, Houben GF, Brooks-Taylor S, et al. Clinical challenge data for development of allergen management thresholds for precautionary labeling of foods- VITAL 2.0. J Allergy Clin Immun 2013, In press.
2. Taylor SL, Crevel RWR, Sheffield D, Kabourek J, Baumert J. Threshold dose for peanut: risk characterization based upon published results from challenges of peanut-allergic individuals. Food Chem Toxicol 2009, 47(6):1198-1204. 10.1016/j.fct.2009.02.011, 19232533.
3. Taylor SL, Moneret-Vautrin DA, Crevel RWR, Sheffield D, Morisset M, Dumont P, et al. Threshold dose for peanut: risk characterization based upon diagnostic oral challenge of a series of 286 peanut-allergic individuals. Food Chem Toxicol 2010, 48(3):814-819. 10.1016/j.fct.2009.12.013, 20034533.
4. Zurzolo GA, Mathai ML, Koplin JJ, Allen KJ. Precautionary allergen labelling following new labelling practice in Australia. J Paediatr Child Health 2013, 49(4):E306. E10, 10.1111/jpc.12138, 23489385.
5. Zurzolo G, Koplin J, Mathai M, Mimi T, Allen K. Perceptions of precautionary labelling among parents of children with food allergy and anaphylaxis. Med J Aust 2013, 198(11):621-623. Epub 2013/08/08, 10.5694/mja12.11669, 23919711.
6. Allergen, Bureau Summary of the VITAL scientific expert panel recommendations 2011, Available from: http://www.allergenbureau.net/downloads/vital/VSEP-Summary-Report-Oct-2011.pdf, Allergen, Bureau.
7. Madsen CB, Hattersley S, Allen KJ, Beyer K, Chan CH, Godefroy SB, et al. Can we define a tolerable level of risk in food allergy? Report from a EuroPrevall/UK Food Standards Agency workshop. Clinical & Experimental Allergy 2012, 42(1):30-37. n/a-n/a, 10.1111/j.1365-2222.2011.03868.x, 24073437.
8. Osborne NJ, Koplin JJ, Martin PE, Gurrin LC, Thiele L, Tang ML, et al. The HealthNuts population-based study of paediatric food allergy: validity, safety and acceptability. Clinical & Experimental Allergy 2010, 40(10):1516-1522. 10.1111/j.1365-2222.2010.03562.x, 24073437.
9. Sampson HA, Gerth van Wijk R, Bindslev-Jensen C, Sicherer S, Teuber SS, Burks AW, et al. Standardizing double-blind, placebo-controlled oral food challenges: American academy of allergy, asthma and immunology-European academy of allergy and clinical immunology PRACTALL consensus report. J Allergy Clin Immun 2012, 130(6):1260-1274. 10.1016/j.jaci.2012.10.017, 23195525.
10. Koplin JJ, Tang MLK, Martin PE, Osborne NJ, Lowe AJ, Ponsonby A-L, et al. Predetermined challenge eligibility and cessation criteria for oral food challenges in the HealthNuts population-based study of infants. J Allergy Clin Immun 2012, 129(4):1145-1147. 10.1016/j.jaci.2011.09.044, 22078469.
11. DunnGalvin A, Hourihane JB. Developmental Aspects of Health Related Quality of Life (HRQL) in Food Related Chronic Disease: the example of food allergy. Handbook of Behavior, Food and Nutrition 2011, 3077-3098. New York: Springer, Preedy VR, Watson RR, Martin CR.
12. DunnGalvin A, Hourihane JOB. Chapter 3 developmental trajectories in food allergy: a review. Advances in food and nutrition research 2009, 65-100. Waltham, Massachusetts, USA: Academic Press, Steve LT.
13. Kruizinga AG, Briggs D, Crevel RWR, Knulst AC, Bosch LMC, Houben GF. Probabilistic risk assessment model for allergens in food: sensitivity analysis of the minimum eliciting dose and food consumption. Food Chem Toxicol 2008, 46(5):1437-1443. 10.1016/j.fct.2007.09.109, 18358932.
14. Madsen CB, Hattersley S, Buck J, Gendel SM, Houben GF, Hourihane JOB, et al. Approaches to risk assessment in food allergy: report from a workshop "developing a framework for assessing the risk from allergenic foods" Food Chem Toxicol 2009, 47(2):480-489. 10.1016/j.fct.2008.12.001, 19101602.
15. Mills ENC, Valovirta E, Madsen C, Taylor SL, Vieths S, Anklam E, et al. Information provision for allergic consumers - where are we going with food allergen labelling?. Allergy 2004, 59(12):1262-1268. 10.1111/j.1398-9995.2004.00720.x, 15507093.
16. Marklund B, Wilde-Larsson B, Ahlstedt S, Nordstrom G. Adolescents' experiences of being food-hypersensitive: a qualitative study. BMC Nurs 2007, 6:8. Epub 2007/10/10, 10.1186/1472-6955-6-8, 2104527, 17922926.
17. Hourihane JOB, Bedwani SJ, Dean TP, Warner JO. Randomised, double blind, crossover challenge study of allergenicity of peanut oils in subjects allergic to peanuts. BMJ 1997, 314(7087):1084. 10.1136/bmj.314.7087.1084, 2126478, 9133891.
18. Madsen CB, Crevel R, Chan C-H, Dubois AEJ, DunnGalvin A, Flokstra-de Blok BMJ, et al. Food allergy: stakeholder perspectives on acceptable risk. Regul Toxicol Pharmacol 2012, 57(2-3):256-265.
19. DunnGalvin A, Cullinane C, Daly DA, Flokstra-de Blok BMJ, Dubois AEJ, Hourihane JOB. Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire - Parent Form in children 0-12 years following positive and negative food challenges. Clinical & Experimental Allergy 2010, 40(3):476-485. 10.1111/j.1365-2222.2010.03454.x, 24073437.
20. DunnGalvin A, Gaffney A, Hourihane JOB. Developmental pathways in food allergy: a new theoretical framework. Allergy 2009, 64(4):560-568. 10.1111/j.1398-9995.2008.01862.x, 19154549.
21. DunnGalvin A, Hourihane JOB. Self-assessment of reaction thresholds in food allergy: a new theory of risk taking which changes over time. J Allergy Clin Immun 2009, 123(2):S142.